跳至主要内容
临床试验/TCTR20231019005
TCTR20231019005招募中1 期

Effect of Mozart K.448 on interictal epileptiform discharges in drug-resistant adult epilepsy patients in King Chulalongkorn Memorial hospital

Chulalongkorn Comprehensive Epilepsy Center of Excellence0 个研究点目标入组 30 人开始时间: 2023年10月19日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.Age more than 18 years old
  • 2.Drug-resistant epilepsy was diagnosed
  • 3.Stable antiseizure medication dose for 1 months before inclusion

排除标准

  • 1.Patients who refused to participate in the research
  • 2.Patients who cannot do an EEG according to the 10-20 principle, such as patients undergoing cranial surgery.
  • 3.Patients with hearing impairment
  • 4.Patient was diagnosed with epilepsy caused by progressive neurological disease such as Rasmussen's encephalitis, mitochondrial disorders, inborn error of metabolism, autoimmune-associated epilepsy, etc.
  • 5.Patients who tend to be unable to tolerate listening to Mozart K.448, such as those with intellectual disabilities and accompanying behavioral problems.
  • 6.In the first 4-hour EEG recording during the first night of the study, there were fewer than 10 interictal epileptiform discharges.
  • 7.The patient has a history of irregular heart rhythm known as atrial fibrillation.
  • 8.The patient has a history of having a permanent pacemaker (PPM) implanted.

研究者

发起方
Chulalongkorn Comprehensive Epilepsy Center of Excellence

相似试验